These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19329550)

  • 1. Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats.
    Cooper GD; Goudie AJ; Halford JC
    J Psychopharmacol; 2010 Jul; 24(7):1069-78. PubMed ID: 19329550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of olanzapine affects Behavioral Satiety Sequence and feeding behavior in female mice.
    Coccurello R; D'Amato FR; Moles A
    Eat Weight Disord; 2008 Sep; 13(3):e55-60. PubMed ID: 19011365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
    Deng C; Lian J; Pai N; Huang XF
    J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats.
    Rodgers RJ; Halford JC; Nunes de Souza RL; Canto de Souza AL; Piper DC; Arch JR; Blundell JE
    Regul Pept; 2000 Dec; 96(1-2):71-84. PubMed ID: 11102655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats.
    Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Rodgers RJ
    Physiol Behav; 2004 Mar; 81(1):129-40. PubMed ID: 15059692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
    Tallett AJ; Blundell JE; Rodgers RJ
    Behav Brain Res; 2009 Mar; 198(2):359-65. PubMed ID: 19061919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
    Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
    Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.
    Tallett AJ; Blundell JE; Rodgers JR
    Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors.
    Roerig JL; Mitchell JE; de Zwaan M; Crosby RD; Gosnell BA; Steffen KJ; Wonderlich SA
    J Clin Psychopharmacol; 2005 Oct; 25(5):413-8. PubMed ID: 16160615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
    Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
    J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence.
    Halford JC; Lawton CL; Blundell JE
    Pharmacol Biochem Behav; 1997 Jan; 56(1):41-6. PubMed ID: 8981607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
    Snigdha S; Thumbi C; Reynolds GP; Neill JC
    J Psychopharmacol; 2008 Jul; 22(5):567-71. PubMed ID: 18208914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of subcutaneous adipose proliferation by olanzapine in rodents.
    Tan W; Fan H; Yu PH
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1098-103. PubMed ID: 20541579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine disrupts the behavioural satiety sequence in rats.
    Montgomery AM; Willner P
    Psychopharmacology (Berl); 1988; 94(3):397-401. PubMed ID: 3128817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats.
    He M; Zhang Q; Deng C; Wang H; Lian J; Huang XF
    Psychoneuroendocrinology; 2014 Apr; 42():153-64. PubMed ID: 24636512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.